BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29573748)

  • 1. High serum levels of caspase-cleaved cytokeratin-18 are associated with malignant middle cerebral artery infarction patient mortality.
    Lorente L; Martín MM; Pérez-Cejas A; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    BMC Neurol; 2018 Mar; 18(1):32. PubMed ID: 29573748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between serum levels of caspase-cleaved cytokeratin-18 and early mortality in patients with severe spontaneous intracerebral hemorrhage.
    Lorente L; Martín MM; Pérez-Cejas A; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    BMC Neurosci; 2018 Apr; 19(1):23. PubMed ID: 29661155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of caspase-cleaved cytokeratin-18 in patients with severe traumatic brain injury are associated with mortality: a pilot study.
    Lorente L; Martín MM; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; Borreguero-León JM
    PLoS One; 2015; 10(3):e0121739. PubMed ID: 25822281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Survivor Ischemic Stroke Patients Maintain High Serum Caspase-Cleaved Cytokeratin-18 Levels.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    Brain Sci; 2020 Feb; 10(3):. PubMed ID: 32120809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher serum caspase-cleaved cytokeratin-18 levels during the first week of sepsis diagnosis in non-survivor patients.
    Lorente L; Martín MM; Pérez-Cejas A; López RO; Ferreres J; Solé-Violán J; Labarta L; Díaz C; Palmero S; Buitrago M; Jiménez A; Borreguero-León JM
    Clin Chem Lab Med; 2017 Aug; 55(10):1621-1629. PubMed ID: 28282291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients.
    Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; González-Rivero AF; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2019 Jul; 19(1):167. PubMed ID: 31319804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Ramos L; Cáceres JJ; Solé-Violán J; Argueso M; Jiménez A; Borreguero-León JM; Orbe J; Rodríguez JA; Páramo JA
    BMC Neurol; 2015 Jul; 15():111. PubMed ID: 26162891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum malondialdehyde levels in patients with malignant middle cerebral artery infarction are associated with mortality.
    Lorente L; Martín MM; Abreu-González P; Ramos L; Argueso M; Solé-Violán J; Riaño-Ruiz M; Jiménez A
    PLoS One; 2015; 10(5):e0125893. PubMed ID: 25933254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels.
    Lorente L; Martín MM; Abreu-González P; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    BMC Neurol; 2019 Oct; 19(1):238. PubMed ID: 31623565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Serum Soluble CD154 Levels and Mortality in Patients with Malignant Middle Cerebral Artery Infarction.
    Lorente L; Martín MM; González-Rivero AF; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM
    Int J Mol Sci; 2015 May; 16(6):12147-58. PubMed ID: 26030673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Levels of B-cell Lymphoma-2 Anti-Apoptotic Protein and Malignant Middle Cerebral Artery Infarction Mortality.
    Lorente L; Martín MM; González-Rivero AF; Pérez-Cejas A; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Villacampa-Jiménez JJ; Jiménez A
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105717. PubMed ID: 33690027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of caspase-cleaved cytokeratin-18 and mortality are associated in severe septic patients: pilot study.
    Lorente L; Martín MM; González-Rivero AF; Ferreres J; Solé-Violán J; Labarta L; Díaz C; Jiménez A; Borreguero-León JM
    PLoS One; 2014; 9(10):e109618. PubMed ID: 25290885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Caspase-3 Levels and Early Mortality of Patients with Malignant Middle Cerebral Artery Infarction.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Sabatel R; Ramos L; Argueso M; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    Neurocrit Care; 2019 Dec; 31(3):486-493. PubMed ID: 31115825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between blood caspase-8 levels and mortality of patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Villacampa-Jiménez JJ; Jiménez A
    Med Intensiva (Engl Ed); 2022 Jun; 46(6):305-311. PubMed ID: 35688578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum substance P levels and mortality after malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    J Crit Care; 2020 Jun; 57():1-4. PubMed ID: 31991332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subacute Elevation of Plasma Level of Caspase-Cleaved Cytokeratin-18 is Associated with Hemorrhagic Transformation and Functional Outcome in Ischemic Stroke.
    Molnar T; Borocz K; Berki T; Szapary L; Szolics A; Janszky J; Illes Z; Csecsei P
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):719-727. PubMed ID: 30528602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Serum sCD40L Levels During the First Week of Malignant Middle Cerebral Artery Infarction and Mortality.
    Lorente L; Martín MM; González-Rivero AF; Sabatel R; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Alvarez-Castillo A; Jiménez A; Borreguero-León JM; García-Marín V
    World Neurosurg; 2019 Dec; 132():e630-e636. PubMed ID: 31442656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Serum Caspase-Cleaved Cytokeratin-18 Levels and Mortality of Traumatic Brain Injury Patients.
    Lorente L; Martín MM; González-Rivero AF; Pérez-Cejas A; Argueso M; Ramos L; Solé-Violán J; Cáceres JJ; Jiménez A; García-Marín V
    Brain Sci; 2019 Oct; 9(10):. PubMed ID: 31658711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of serum caspase-cleaved cytokeratin-18 concentrations after acute intracerebral hemorrhage.
    Gu SJ; Lu M; Xuan HF; Chen XZ; Dong WF; Yan XF; Si Y; Gao GL; Hu DX; Miao JQ
    Clin Chim Acta; 2016 Jan; 452():124-8. PubMed ID: 26569346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between blood caspase-8 levels and mortality of patients with malignant middle cerebral artery infarction.
    Lorente L; Martín MM; Pérez-Cejas A; González-Rivero AF; Ramos-Gómez L; Solé-Violán J; Cáceres JJ; Villacampa-Jiménez JJ; Jiménez A
    Med Intensiva (Engl Ed); 2021 Apr; ():. PubMed ID: 33926751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.